XORTX Therapeutics Ownership | Who Owns XORTX Therapeutics?

XORTX Therapeutics Ownership Summary

XORTX Therapeutics is owned by 0.65% institutional investors, and 99.35% retail investors.

XRTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	XORTX Therapeutics	0.65%	-	99.35%
Sector	Healthcare Stocks	47.25%	8.01%	44.75%
Industry	Biotech Stocks	45.35%	7.81%	46.83%

XRTX Ownership FAQ

Who Owns XORTX Therapeutics?

XORTX Therapeutics shareholders are primarily institutional investors at 0.65%, followed by 0% insiders and 0% retail investors. The average institutional ownership in XORTX Therapeutics's industry, Biotech Stocks , is 45.35%, which XORTX Therapeutics falls below.

Does Blackrock own XORTX Therapeutics?

BlackRock is not among the top 10 institutional shareholders of XORTX Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools